Using a new animal model for drug screening and evaluation technology for new drug development, Hangzhou Leiso Pharmaceutical Co., Ltd. is a high-tech new drug company with an advanced scientific and technological level. The company was founded in 2011 by a team of overseas returned drug researchers who have served as senior executives in top contract research organizations.

The scientists of Leisuo Pharma are dedicated to research and development of medications for serious illnesses like tumors, chronic inflammation, immune disorders, and metabolic disorders, with a focus on the identification of novel drug targets for diseases listed above and discovery and evaluation of structurally novel lead compounds.